Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07492095

Leucine Requirements in School-Age Children

Leucine is an essential amino acid, which serves a special purpose of signaling cell growth in muscle in addition to making up protein. Essential amino acids like leucine need to be eaten every day from our foods like meat, dairy, eggs, beans, and nuts, as they cannot be made by our bodies. The current recommendation for leucine in the diet of school-age children are based upon adult needs. This study will measure the leucine requirement in children aged 6-10 years old using an non-invasive technique with special diets, safe stable isotopes, and simple breath collections. Creating guidelines based on measured requirements for leucine in this age group is essential for supporting optimal growth in healthy children.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

6 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

BC Children's Hospital Research Institute

Vancouver, British Columbia, V5Z 4H4, Canada

Location status: Recruiting

Location contact

Rajavel Elango

PRINCIPAL_INVESTIGATOR

About this study

Purpose:

  • The purpose of this study is to determine the requirement of the essential amino acid leucine, in school-aged children (6-10 years old), with the minimally invasive indicator amino acid oxidation (IAAO) protocol.

Hypothesis:

  • The leucine requirement for healthy school-age children is higher than current 2005 recommendation of 40-49 mg/kg/d when measured using the IAAO method.

Justification:

  • Protein is essential for growth, tissue repair, and maintenance of physiological functions throughout the lifecycle. Dietary protein is particularly important during childhood to support a healthy growth trajectory and lean body mass development. Despite the importance of protein to support early life growth and development, childhood protein requirements are largely extrapolated from adult values, and not on pediatric-specific data. Consequently, the current leucine recommendations for children of 40-49 mg/kg/d may not accurately reflect the physiological needs of growth.

Objectives:

  • Primary Objective: To determine the leucine requirement in healthy school-aged children using IAAO.
  • Secondary Objective: To quantify urinary flux of L-[1-13C] phenylalanine as an additional measure of amino acid metabolism during the experimental protocol.

Research Design:

  • Randomized crossover metabolic design based on the IAAO technique to estimate the minimum dietary requirement for leucine. The repeated measures study design involves 7 children (participants) completing 1 pre-study visit and 5 IAAO study visits each with a randomized leucine intake.
  • After a 10h fast, each child (participant) is randomized to receive 1 of 7 leucine intake levels (10, 20, 30, 40, 50, 60 or 80 mg/kg/d). On the study day, the diet is administered hourly as eight isonitrogenous, isocaloric meals. Each meal consists of two protein-free cookies and a formulated drink prepared with crystalline amino acids, a flavoured protein-free liquid (powdered drink mix), and corn oil. Multivitamin supplements are provided throughout the study to ensure adequate micronutrient intake. The study diet provides an energy intake equivalent to 1.7 x resting energy expenditure and 1.5 g/kg protein.
  • The principle underlying IAAO is that when the intake of an essential amino acid is insufficient, protein synthesis cannot proceed, and the remaining amino acids, unable to be stored, are oxidized. This physiological process can be leveraged by administering a stable isotope-labeled "indicator" amino acid, L-[1-13C]-phenylalanine. When requirements are met, the indicator is incorporated into body protein, but when an amino acid is limiting, the indicator is oxidized, and its labeled carbon appears as 13CO2 in the breath.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy children
  • Aged 6 to 10 years at enrollment
  • Body weight between the 3rd and 85th percentile according to WHO Child Growth Standards
  • Assent from the child and written informed consent from parent(s) and/or legal guardian(s)

Exclusion criteria

  • Diagnosis of any acute or chronic medical condition
  • Current use of prescription medication that may affect protein or energy metabolism
  • Recent weight loss
  • Recent illness (fever, vomiting, severe runny nose within the past 5 days)
  • Inability to comply with study procedures

Treatment and study plan

Leucine Intake

Dietary Supplement

Participants consume 8 hourly meals that contain the assigned test leucine intake. Each meal will provide one-twelfth of the participants' daily energy requirements as estimated by 1.7 x Resting Energy Expenditure (REE) and adequate protein at 1.5 g/kg/d, to maintain a metabolic steady state. The meals are in the form of a crystalline amino acid protein shake, and protein-free cookies.

Primary outcomes

  1. Carbon-13 Oxidation

    Time frame: 8 hours (1 study day)

    9 breath samples will be collected during the study day, to measure the rate of oxidation of tracer phenylalanine in the expired breath.

Secondary outcomes

  1. Urinary L-[1-13C] Phenylalanine Flux

    Time frame: 8 hours (1 study day)

    3 urine samples will be collected during the study day to measure urinary excretion of phenylalanine

Study contacts

Contact information is provided by the study sponsor or research team.

Kendall Plant

CONTACT

[email protected]

604-875-2000 ext. 4607

Rajavel Elango

CONTACT

[email protected]

604-875-2000 ext. 4911

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

Determination of Leucine Requirements in Healthy School-Age Children Using the Indicator Amino Acid Oxidation Method

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 25, 2026
Registry last updated
Jul 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.